Testing effectiveness (Phase 2)Looking for participantsNCT06526819What this trial is testingSMP-3124LP in Adults With Advanced Solid TumorsWho this might be right forSolid Tumor Sumitomo Pharma America, Inc. 120
Early research (Phase 1)Ended earlyNCT04978779What this trial is testingEvaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter SyndromeWho this might be right forRelapsed Non Hodgkin LymphomaChronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia+4 more Vincerx Pharma, Inc. 6
Early research (Phase 1)Ended earlyNCT05067972What this trial is testingPF-07260437 in Advanced or Metastatic Solid TumorsWho this might be right forOvarian NeoplasmsEndometrial NeoplasmsBreast Neoplasms Pfizer 30
Very early researchStudy completedNCT04733027What this trial is testingFirst-in-human Phase I to Evaluate PEP-010 as Single Agent and in Combination With Paclitaxel or With Gemcitabine (CleverPeptide)Who this might be right forMetastatic Solid Tumor Cancer Institut Curie 77
Early research (Phase 1)Looking for participantsNCT07538479What this trial is testingControlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)Who this might be right forSolid TumorsSolid MalignanciesCold Exposure+1 more West China Hospital 24
Early research (Phase 1)Looking for participantsNCT06026410What this trial is testingKO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsWho this might be right forSolid Tumors With HRAS AlterationsNon Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+4 more Kura Oncology, Inc. 300
Early research (Phase 1)Ended earlyNCT05781360What this trial is testingInvestigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid TumorsWho this might be right forLocally Advanced Unresectable or Metastatic Solid Tumor Jiangsu Simcere Pharmaceutical Co., Ltd. 192
Testing effectiveness (Phase 2)Looking for participantsNCT05689853What this trial is testingStudy of AK119 Combined With AK112 in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Akeso 87
Testing effectiveness (Phase 2)Study completedNCT03724851What this trial is testingVactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric CancerWho this might be right forMetastatic Colorectal CancerGastric CancerGastroesophageal Junction Adenocarcinoma MedPacto, Inc. 120
Early research (Phase 1)Study completedNCT00045370What this trial is testingChemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney Cancer Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00879866What this trial is testingEMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)Who this might be right forLung CancerNon Small Cell Lung Cancer Merck KGaA, Darmstadt, Germany 15
Early research (Phase 1)Ended earlyNCT05309512What this trial is testingClinical Study of KN052 in Chinese Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Jiangsu Alphamab Biopharmaceuticals Co., Ltd 15
Early research (Phase 1)Ended earlyNCT03621982What this trial is testingStudy of ADCT-301 in Patients With Selected Advanced Solid TumorsWho this might be right forHead and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more ADC Therapeutics S.A. 78
Early research (Phase 1)Looking for participantsNCT06736327What this trial is testingA Study on the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SKB500 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 180
Early research (Phase 1)Ended earlyNCT05387265What this trial is testingA Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid TumorsWho this might be right forSolid Tumors CytomX Therapeutics 83
Testing effectiveness (Phase 2)Study completedNCT02118337What this trial is testingA Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced MalignanciesWho this might be right forSelect Advanced MalignanciesKidney CancerClear Cell Renal Cell Carcinoma MedImmune LLC 97
Testing effectiveness (Phase 2)Looking for participantsNCT06609005What this trial is testingEvaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate CancerWho this might be right forAdvanced Metastatic Castration Resistant Prostate Cancer Shenzhen Ionova Life Sciences Co., Ltd. 84
Testing effectiveness (Phase 2)Looking for participantsNCT05588648What this trial is testingStudy to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive OsteosarcomaWho this might be right forOsteosarcoma MedPacto, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT06797999What this trial is testingFirst-in-Human Study of ADCE-D01 in Soft Tissue SarcomaWho this might be right forMetastatic Soft Tissue SarcomaUnresectable Soft Tissue Sarcoma Adcendo ApS 270
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770698What this trial is testingSonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic LeukemiaWho this might be right forRelapsed Acute Myeloid LeukemiaRefractory Acute Myeloid LeukemiaB-cell Acute Lymphoblastic Leukemia+9 more BeOne Medicines 30